Business Segment Information - Summary of EBIDTA by Reporting Segment (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Segment Reporting Information [Line Items]
Segment Adjusted EBITDA	$ 112,007	$ 91,557	$ 67,960
Interest expense, net	29,631	8,631	1,288
Depreciation and amortization	60,061	53,063	29,019
Share-based compensation expense	32,455	35,707	18,443
Foreign exchange impact	4,395	(1,581)	3,291
SeaSpine merger-related costs	14,485	36,577	11,902
Strategic investments	910	2,272	4,018
Acquisition-related fair value adjustments	19,088	33,393	(15,595)
Interest and loss on investments	5,120	1,781	187
Litigation and investigation costs	15,770	14,453	803
Succession charges	9,376	1,176	147
Medical device regulation		9,492	10,370
Business interruption - COVID-19			2,387
Loss before income taxes	(123,875)	(148,679)	(17,706)
Global Spine [Member]
Segment Reporting Information [Line Items]
Segment Adjusted EBITDA	107,386	91,115	62,693
Global Orthopedics [Member]
Segment Reporting Information [Line Items]
Segment Adjusted EBITDA	4,621	442	5,267
Operating Segments [Member]
Segment Reporting Information [Line Items]
Segment Adjusted EBITDA	799,491	746,641	460,713
Non-GAAP Cost of sales	231,702	214,813	119,357
Non-GAAP Sales, general, and administrative	439,002	423,642	261,600
Non-GAAP Research and development	71,416	67,238	37,584
Other segment expenses (benefits)	(76)	(37)	(232)
Non-GAAP Depreciation, amortization, and share-based compensation expense	54,560	50,572	25,556
Operating Segments [Member] | Global Spine [Member]
Segment Reporting Information [Line Items]
Segment Adjusted EBITDA	675,314	631,319	353,174
Non-GAAP Cost of sales	183,064	166,885	74,573
Non-GAAP Sales, general, and administrative	368,817	355,827	204,840
Non-GAAP Research and development	58,262	56,512	29,220
Other segment expenses (benefits)	(22)	45	(183)
Non-GAAP Depreciation, amortization, and share-based compensation expense	42,193	39,065	17,969
Operating Segments [Member] | Global Orthopedics [Member]
Segment Reporting Information [Line Items]
Segment Adjusted EBITDA	124,177	115,322	107,539
Non-GAAP Cost of sales	48,638	47,928	44,784
Non-GAAP Sales, general, and administrative	70,185	67,815	56,760
Non-GAAP Research and development	13,154	10,726	8,364
Other segment expenses (benefits)	(54)	(82)	(49)
Non-GAAP Depreciation, amortization, and share-based compensation expense	12,367	11,507	7,587
Corporate, Non-Segment [Member]
Segment Reporting Information [Line Items]
Segment Adjusted EBITDA	$ 44,591	$ 45,272	$ 19,406